SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-004109
Filing Date
2017-01-26
Accepted
2017-01-26 18:07:48
Documents
1
Period of Report
2017-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 v457642_form4.html 4  
1 FORM 4 v457642_form4.xml 4 4176
  Complete submission text file 0001144204-17-004109.txt   5619
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1

Mailing Address C/O INTERLEUKIN GENETICS INC 135 BEAVER STREET WALTHAM MA 02452
Business Address
KORNMAN KENNETH S (Reporting) CIK: 0001237192 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32715 | Film No.: 17551196